Your trusted source for investing success

Tag: matrix

First Cobalt Announces Kipoi East Exploration Program

First Cobalt Corp. (TSXV:FCC)(OTCQB:FTSSF) (the “Company”) today announced its exploration program at its Kipoi East Project in Katanga province, Democratic Republic of the Congo. The program is scheduled to commence immediately following the definitive joint venture agreement execution.

Highlights

US$650,000 exploration program for the Kipoi East property, a 23 square-kilometre property

Leading Edge Materials Partners in Graphene Aeronautic Composite Technology Project Using Graphite from the Woxna Project, Sweden

Leading Edge Materials Partners in Graphene Aeronautic Composite Technology Project Using Graphite from the Woxna Project, Sweden

Leading Edge Materials Corp. (TSXV:LEM) or (the Company”) (TSXV:LEM) (OTCQB: LEMIF) is pleased to announce the commencement of a VINNOVA funded research project, where the Company is a founding participant, involving the use of graphite and graphene in high performance polymeric composite materials.  The project, entitled “Graphene Modified Composites for

Otis Commences Exploration Program at Oakley

Otis Commences Exploration Program at Oakley

Otis Gold Corp.  (TSXV:OOO) (the “Company” or “Otis”) is pleased to announce the commencement of field work at its Oakley Project (“Oakley”), Cassia County, Idaho. The phase one program consists of geologic mapping and surface sampling at Matrix Creek, an emerging exploration target at Oakley. Prior Otis field work (see

NextSource Materials Inc. Announces Positive Updated Feasibility Study for Phase 1 Modular Mine Production of 17,000 Tonnes Per Year

NextSource Materials Inc. Announces Positive Updated Feasibility Study for Phase 1 Modular Mine Production of 17,000 Tonnes Per Year

 
Highlights:

The updated Feasibility Study results verify positive economics for Phase 1 of the Molo mine, which will utilize a unique, fully-modular build approach taking into account current-day flake graphite prices.

The updated Feasibility Study is based on Front End Engineering and Design (FEED), and Detailed Engineering studies as opposed

Drilling Extends High Grade Nickel-Copper Sulphides at Cathedrals Prospect

St George Mining (ASX: SGQ) (‘St George Mining’ or ‘the Company’) is pleased to announce that further massive nickel-copper sulphides have been intersected at the Cathedrals Prospect which is currently being drilled at the Mt Alexander Project in Western Australia.

Four new drill holes have been completed at the Cathedrals Prospect,

DRILLING INTERSECTS THICK MINERALISED ULTRAMAFIC CHANNEL AT MT ALEXANDER

Highlights:

Stricklands Prospect:

 MAD49 at the Stricklands Prospect intersects a thick 22m interval of nickel-copper sulphide mineralisation comprising disseminated, matrix and massive sulphides at a shallow depth of 31.8m from surface
 MAD52 intersects 2.97m of matrix and massive sulphides 300m to the east of MAD49 from drill testing outside the modelled

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083 as a Front-Line Treatment for Glioblastoma Multiforme

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it has entered into a three-year collaboration with Duke University to evaluate VAL-083, the Company’s platform compound, as a front-line treatment for newly diagnosed patients with glioblastoma multiforme (“GBM”).

DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting

DelMar Pharmaceuticals Provides VAL-083 Updates from the Ongoing American Association for Cancer Research (AACR) Annual Meeting

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it has presented three abstracts at the American Association for Cancer Research (AACR) Annual Meeting. These abstracts are all focused on pre-clinical research to elucidate the mechanism of action (MOA) of

DelMar Pharmaceuticals Announces Abstract Presentations for the American Association for Cancer Research (AACR) Annual Meeting in April 2017

DelMar Pharmaceuticals Announces Abstract Presentations for the American Association for Cancer Research (AACR) Annual Meeting in April 2017

DelMar Pharmaceuticals (NASDAQ:DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it will present three abstracts at the American Association of Cancer Research (AACR) Annual Meeting. The abstracts are based on research conducted with DelMar’s lead anti-cancer product candidate, VAL-083 (dianhydrogalactitol), a

Gold Outlook 2017!

Click here to get a clear perspective on the gold price and what the experts see coming in 2017 with our FREE Special Report (value of $49). Limited time offer. No credit card required.   Get My Free Report  
Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network